Malecare announces the addition of our latest and informative teleconference about Immunotherapy and Advanced Prostate Cancer.  Joining me in the conference is Dr. Nicholas J. Vogelzang, M.D., a medical oncologist with the Comprehensive Cancer Centers of Nevada (CCCN) and serves as chair and site research leader, and as medical director of the Developmental Therapeutics Committee and Member of the Genitourinary Committee for US Oncology Research.  This conference was
produced with generous support from Bavarian Nordic.

A full recording of the conference as well as a written transcript is now available at:  Click through to the teleconference page.

This teleconference joins the following, all of which are available to listen to and to read the transcript:


Bone Health and Prostate Cancer with Doctor Neal Shore.  (produced with generous support from Bayer ).  Learn about the importance of and how to maintain bone health when you ave prostate cancer.
New Prostate Cancer Tests with Drs. Daniel Lieber and Steve Hershman.  The teleconference explored the current state of affairs of genetic testing and prostate cancer.


All About New Options for Men with Advanced Prostate Cancer with Dr. James Gulley from the National Cancer Institute (NCI).  Dr. Gulley talked about advanced prostate cancer treatments, immunotherapy and clinical trials.


All About Provenge was discussed by Dr. Neal Shore. Provenge, the only approved immunotherapy to treat advanced prostate cancer.


Dr. James McKiernan provided us with a general conversation about advanced prostate cancer.



Joel T Nowak, M.A., M.S.W.